https://blog.lifesciencenation.com/2026/11/03/hot-investor-mandate-us-based-vc-firm-invests-250k-3m-in-seed-and-series-a-healthtech-medtech-and-biotechnology-companies/Next Phase Newsletteren2026-11-03T17:28:43+00:00Hot Investor Mandate: US-Based VC Firm Invests $250K–$3M in Seed and Series A HealthTech, MedTech, and Biotechnology Companiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/03/hot-investor-mandate-global-therapeutics-vc-invests-up-to-5-6m-in-seed-to-series-b-genetic-medicine-and-advanced-therapeutic-modalities/Next Phase Newsletteren2026-11-03T17:28:25+00:00Hot Investor Mandate: Global Therapeutics VC Invests Up to $5-6M in Seed to Series B Genetic Medicine and Advanced Therapeutic Modalitiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/03/hot-investor-mandate-healthcare-focused-impact-vc-targets-series-a-oncology-therapeutics-and-cardiovascular-medical-devices/Next Phase Newsletteren2026-11-03T17:28:05+00:00Hot Investor Mandate: Healthcare-Focused Impact VC Targets Series A Oncology Therapeutics and Cardiovascular Medical Devicestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/03/hot-investor-mandate-global-life-sciences-cvc-invests-in-series-a-and-b-therapeutics-diagnostics-and-drug-discovery-technologies/Next Phase Newsletteren2026-11-03T17:27:47+00:00Hot Investor Mandate: Global Life Sciences CVC Invests in Series A and B Therapeutics, Diagnostics, and Drug Discovery Technologiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence